AstraZeneca and Honeywell are developing MDIs that will use a new propellant called HFO-1234ze, which, according to the company, has 99.9% less Global Warming Potential (GWP) than existing ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

(RTTNews) - AstraZeneca PLC (AZN, AZN.L) announced Wednesday that its Fasenra (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with ...

The FluMist vaccine, manufactured by AstraZeneca, had previously been approved back in 2003 to be given by health care providers similar to other flu shots. Now the vaccinemaker has approval to ...

FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States since 2003. It’s currently available in pharmacies and other health care ...

Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L), opens new tab nasal spray flu vaccine for self-administration, making it the first ...

The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription. By Christina Jewett The Food and Drug Administration on ...

Welcome, ladies and gentlemen, to AstraZeneca's Investor Conference Call ESMO 2024. Before I hand over to AstraZeneca's management team, I'd like to read the safe harbor statement. The Company ...

As of September 19, 2024, AstraZeneca plc (ADR) had a $242.8 billion market capitalization, putting it in the 99th percentile of companies in the Pharmaceuticals industry. Currently, AstraZeneca plc ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 17,182.38 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...